<table id="table5" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 5: SIROLIMUS WHOLE BLOOD TROUGH CONCENTRATIONS OBSERVED IN RENAL TRANSPLANT PATIENTS ENROLLED IN PHASE 3 STUDIES</caption>
<col align="left" valign="top" width="25%"></col>
<col align="left" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<thead>
<tr>
<th rowspan="2" valign="bottom">Patient Population(Study number)</th>
<th align="center" rowspan="2" valign="middle">Treatment</th>
<th colspan="2" valign="bottom">Year 1</th>
<th colspan="2" valign="bottom">Year 3</th>
</tr>
<tr>
<th align="center">Mean<br/>(ng/mL)</th>
<th align="center" valign="bottom">10<sup>th</sup> – 90<sup>th</sup> percentiles<br/>(ng/mL)</th>
<th>Mean<br/>(ng/mL)</th>
<th valign="bottom">10<sup>th</sup> – 90<sup>th</sup> percentiles<br/>(ng/mL)</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td rowspan="2">Low-to-moderate risk<br/>(Studies 1 &amp; 2)</td>
<td>Sirolimus<br/>(2 mg/day) + CsA</td>
<td>7.2</td>
<td>3.6 – 11</td>
<td>–</td>
<td>–</td>
</tr>
<tr stylecode="Botrule">
<td>Sirolimus<br/>(5 mg/day) + CsA</td>
<td align="center">14</td>
<td>8 – 22</td>
<td>–</td>
<td>–</td>
</tr>
<tr stylecode="Botrule">
<td rowspan="2">Low-to-moderate risk<br/>(Study 3)</td>
<td>Sirolimus + CsA</td>
<td>8.6</td>
<td>5 – 13<footnote id="t5f1">Months 4 through 12</footnote>
</td>
<td>9.1</td>
<td>5.4 – 14</td>
</tr>
<tr stylecode="Botrule">
<td>Sirolimus alone</td>
<td align="center">19</td>
<td>14 – 22<footnoteref idref="t5f1"></footnoteref>
</td>
<td>16</td>
<td>11 – 22</td>
</tr>
<tr stylecode="Botrule">
<td>High risk<br/>(Study 4)</td>
<td>Sirolimus + CsA</td>
<td>15.7<br/>11.8<br/>11.5</td>
<td>5.4 – 27.3<footnote>Up to Week 2; observed CsA C<sub>min</sub> was 217 (56 – 432) ng/mL</footnote>
<br/>6.2 – 16.9<footnote>Week 2 to Week 26; observed CsA C<sub>min</sub> range was 174 (71 – 288) ng/mL</footnote>
<br/>6.3 – 17.3<footnote>Week 26 to Week 52; observed CsA C<sub>min</sub> was 136 (54.5 – 218) ng/mL</footnote>
</td>
<td>–</td>
<td>–</td>
</tr>
</tbody>
</table>